Stocks in the Drug Manufacturers - Major Industry

Sector: Healthcare

Drug Manufacturers - Major is an industry that produces pharmaceuticals, biologics, and medical devices. This industry is responsible for the research, development, and production of drugs and medical devices that are used to treat and prevent diseases. The industry is highly regulated and requires companies to adhere to strict safety and quality standards. Companies in this industry are typically large, multinational corporations that have the resources to invest in research and development.


Recent Signals

Date Stock Signal Type
2024-07-01 ALIM Narrow Range Bar Range Contraction
2024-07-01 ALIM Calm After Storm Range Contraction
2024-07-01 AZN Bollinger Band Squeeze Range Contraction
2024-07-01 BIIB Shooting Star Candlestick Bearish
2024-07-01 BIIB Doji - Bearish? Reversal
2024-07-01 BIIB Lizard Bearish Bearish Day Trade Setup
2024-07-01 BIIB Cup with Handle Other
2024-07-01 BIIB 200 DMA Resistance Bearish
2024-07-01 BMY 20 DMA Resistance Bearish
2024-07-01 GRFS Lower Bollinger Band Walk Weakness
2024-07-01 GSK Calm After Storm Range Contraction
2024-07-01 GSK 200 DMA Resistance Bearish
2024-07-01 HCM Slingshot Bearish Bearish Swing Setup
2024-07-01 HCM Pocket Pivot Bullish Swing Setup
2024-07-01 HCM Bollinger Band Squeeze Range Contraction
2024-07-01 HCM Crossed Above 200 DMA Bullish
2024-07-01 JNJ 50 DMA Resistance Bearish
2024-07-01 JNJ 20 DMA Resistance Bearish
2024-07-01 JNJ Bollinger Band Squeeze Range Contraction
2024-07-01 JNJ Cup with Handle Other
2024-07-01 LLY New 52 Week High Strength
2024-07-01 LLY 180 Bullish Setup Bullish Swing Setup
2024-07-01 LLY Slingshot Bullish Bullish Swing Setup
2024-07-01 LLY New 52 Week Closing High Bullish
2024-07-01 MRK 50 DMA Resistance Bearish
2024-07-01 NVS Doji - Bearish? Reversal
2024-07-01 NVS Shooting Star Candlestick Bearish
2024-07-01 NVS Bollinger Band Squeeze Range Contraction
2024-07-01 PFE Crossed Above 200 DMA Bullish
2024-07-01 PFE Crossed Above 20 DMA Bullish
2024-07-01 PRPH Lower Bollinger Band Walk Weakness
2024-07-01 PRPH New 52 Week Low Weakness
2024-07-01 PRPH New 52 Week Closing Low Bearish
2024-07-01 RMTI Lower Bollinger Band Walk Weakness
2024-07-01 RMTI New Downtrend Bearish
2024-07-01 RMTI Fell Below 200 DMA Bearish
2024-07-01 RMTI Fell Below 50 DMA Bearish
2024-07-01 RMTI 180 Bearish Setup Bearish Swing Setup
2024-07-01 RMTI MACD Bearish Centerline Cross Bearish
2024-07-01 RMTI Stochastic Reached Oversold Weakness
2024-07-01 SNY NR7 Range Contraction
2024-07-01 SNY Narrow Range Bar Range Contraction
2024-07-01 SNY Cup with Handle Other
2024-07-01 SNY Calm After Storm Range Contraction
2024-07-01 TVTX Spinning Top Other
2024-07-01 TVTX Upper Bollinger Band Walk Strength
2024-07-01 TVTX NR7 Range Contraction

Recent News for Drug Manufacturers - Major Stocks

Date Stock Title
Jul 1 LLY Lilly in deal with Radionetics Oncology on radiopharmaceuticals development
Jul 1 AZN AstraZeneca's COVID-19 Prevention Drug For Patients With Weak Immune Systems - European Medicines Agency Accepts Marketing Application Under Accelerated Assessment
Jul 1 BMY What the Options Market Tells Us About Bristol-Myers Squibb
Jul 1 PFE A standard approach to drug development for accessing the globe
Jul 1 SNY Sanofi Nears Decision on $1.6B Upgrade For Frankfurt Insulin Plant
Jul 1 LLY Sanofi Nears Decision on $1.6B Upgrade For Frankfurt Insulin Plant
Jul 1 BMY Bristol-Myers Squibb to Pay $2.7 Million to Settle Potential Anti-Competition Case, Israeli Agency Says
Jul 1 PFE 2 High-Yielding Healthcare Stocks to Buy With $1,000 in July
Jul 1 ABBV 2 High-Yielding Healthcare Stocks to Buy With $1,000 in July
Jul 1 SNY Bird Flu Shot Hopes Dim as Tracing Woes Undercut Covid Lessons
Jul 1 LLY Eli Lilly Soars To 52-Week High: Can The Momentum Continue?
Jul 1 GILD Gilead Benefit Helps Employees Navigate Cancer Care
Jul 1 ABBV AbbVie (ABBV) Gets CHMP Nod for Lymphoma Drug's Expanded Use
Jul 1 ABBV AbbVie names Robert A. Michael to CEO role
Jul 1 MRK Merck and Orion Announce Mutual Exercise of Option Providing Merck Global Exclusive Rights to Opevesostat, an Investigational CYP11A1 Inhibitor, for the Treatment of Metastatic Castration-Resistant Prostate Cancer
Jul 1 PFE Should You Expect Upside Potential For Pfizer (PFE)?
Jul 1 BMY Bristol Myers to pay $2.7 million to settle Israel anti-competition charges
Jul 1 ABBV Robert A. Michael Assumes Role as AbbVie Chief Executive Officer
Jul 1 LLY Nvidia Among Biggest Stock Market Winners In 2024, But This Is No. 1
Jul 1 LLY Eli Lilly & Co (NYSE:LLY): Jim Cramer’s Best Weight Loss Stock Pick for 2024